Enthusiastic predictions from industry leaders for ongoing progress in obesity, oncology, immunology, neuroscience and more were supported by optimism for the potential of AI and other technological advances to enable breakthroughs in processes as well as pipelines.

Read more here

Previous
Japan strengthening biopharma capabilities
Next
From Discovery to Therapy: The Rise of Reprogrammed Tregs